Blog Posts by Date: Apr 2020


CMS Suspends the Expansion of the Accelerated and Advance Payments Program During the COVID-19 Pandemic for Part B Suppliers

Effective April 26, 2020, CMS is no longer accepting new applications for Advanced Payment Program loans from Part B suppliers including laboratories and reevaluating all new and pending applications for the Accelerated Payment Program.1 Since the announcement of the Expanded Accelerated and Advanced Payment Program on March 28, 2020, CMS has...

Read



Appreciation for Dedicated Lab Warriors

Laboratory Professionals Week, April 19-25, is an annual celebration of lab professionals and pathologists who play a vital role in healthcare and patient advocacy.This year, Lab Week is occurring while lab professionals and pathologists are staunchly working and sacrificing on the front lines of the...

Read



COVID-19: Maintaining Momentum During Volume Recessions

Pathology practices and laboratories across the country have begun to feel the financial impact of COVID-19. With most states placing a moratorium on elective surgeries until late April, or strongly recommending it, diagnostics providers are seeing anywhere from a 30-60% drop in their outreach volumes (see our Lab Volume Index for a more detailed...

Read



The Marriage of Diagnostic Data and Artificial Intelligence to Dramatically Improve Health System Decision Making

Diagnostic data is transformative yet often underutilized. The volume of diagnostic claims and their related financial data is ripe for harvesting insights that can be a catalyst for health system decision making. Identifying leading indicators such as payor behavior and reimbursement trends can assist outreach programs and laboratories in...

Read



CMS Expands Payment Program to Provide Labs Temporary Relief from Declining Revenues

Due to the impact of the recent coronavirus pandemic, CMS Administrator Seema Verma has expanded the CMS Accelerated and Advance Payment Program for the duration of the public health emergency.1 The streamlined process designed to assist healthcare providers and suppliers “stay afloat” during the current COVID-19 crisis will now take days rather...

Read



XIFIN Joins COVID-19 Healthcare Coalition

Laboratory diagnostics have a critical role to play in the current novel Coronavirus (COVID-29) pandemic, and laboratories nationwide are rising to the challenge of supporting the influx of needed coronavirus testing, which is key to managing the pandemic and refining the models that inform public policy. As a committed partner to diagnostic...

Read



Is Your Lab Developing COVID Related Tests? Receive Federal Funding Resources

In response to the COVID-19 global pandemic, the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), has expanded funding opportunities up to $749K to establish public-private partnerships with diagnostic providers for the purpose of developing...

Read



Implementing a Remote Working Environment in Response to COVID-19? A Checklist to Get You Started

Kevin Hagen Vice President of Information Systems, XIFIN Mitch Fry Vice President of Sales, XIFIN Depending on their location in the country, laboratory billing departments have already moved or are starting to move their billing and...

Read